Latest From Bionomics Ltd.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Tonix Pharmaceuticals has won a breakthrough therapy designation this month for its post-traumatic stress disorder drug – the most advanced product in development specifically for the condition and potentially the first ever to market targeting PTSD as its lead indication.
Dr Phil Kearney, MSD director (business development and licensing), India, South East Asia, Australia and New Zealand and ''scout'' behind Merck's Bionomics find, underscores that India, traditionally seen as a base for low FTE (full time equivalent) agreements, generic and follow-on innovations, has moved up the value chain.
Drug Discovery Tools
- Drug Discovery Tools
- Therapeutic Areas
- Immune Disorders
- Neurology, Nervous System
- Parent & Subsidiaries
- Bionomics Ltd.
- Senior Management
Deborah Rathjen, PhD, CEO & Mng. Dir.
Melanie Young, CFO
Gabriel Kremmidiotis, PhD, VP, R&D
Forrest H Fuller, PhD, VP, Bus. Dev.
- Contact Info
Phone: (61) 8 8354 6100
31 Dalgleish St.
Thebarton, SA 5031
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.